Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through ...

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...

However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose UDCA in patients with primary sclerosing cholangitis (PSC) may be harmful; adverse events ...

Chemomab Therapeutics (CMMB) announced that data from its Phase 2 SPRING trial in patients with primary sclerosing cholangitis was presented at ...

An Albuquerque hot air balloon pilot has taken on a new role of becoming his own biggest health advocate in order to get a ...

Examples include primary sclerosing cholangitis, secondary sclerosing cholangitis and biliary atresia. Intrahepatic cholangiocarcinoma (ICC) remains poorly characterised in Chinese patients.

The grant will support Perspectum’s research into the development of a novel biomarker for primary sclerosing cholangitis ...

On October 15, 2024, Chemomab announced that on November 18, 2024, PSC expert Dr. Christopher Bowlus will be presenting a late-breaking oral presentation discussing the CM-101 PSC Phase 2 SPRING trial ...

INTEGRIS-PSC featured in an oral late breaker presentationSOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...

Green is one of the subjects in the first episode of the four-part series produced by Vancouver production company Omnifilm ...